The Novel mTOR Inhibitor RAD001 (Everolimus) Induces Antiproliferative Effects in Human Pancreatic Neuroendocrine Tumor Cells

Publisher： Karger

E-ISSN： 1423-0194|85|1|54-60

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.85, Iss.1, 2007-02, pp. : 54-60

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Octreotide and the mTOR Inhibitor RAD001 (Everolimus) Block Proliferation and Interact with the Akt-mTOR-p70S6K Pathway in a Neuro-Endocrine Tumour Cell Line

By  

Neuroendocrinology, Vol. 87, Iss. 3, 2007-11 ,pp. : 168-181

Karger

Access to resources Recommend Favorite

Abrogation of Autophagy by Chloroquine Alone or in Combination with mTOR Inhibitors Induces Apoptosis in Neuroendocrine Tumor Cells

By  

Neuroendocrinology, Vol. 103, Iss. 6, 2015-12 ,pp. : 724-737

Karger

Access to resources Recommend Favorite

Synergistic Effects of Erlotinib and Everolimus on Bronchial Carcinoids and Large-Cell Neuroendocrine Carcinomas with Activated EGFR/AKT/mTOR Pathway

By  

Neuroendocrinology, Vol. 96, Iss. 3, 2012-02 ,pp. : 228-237

Karger

Access to resources Recommend Favorite

ZM447439, a Novel Promising Aurora Kinase Inhibitor, Provokes Antiproliferative and Proapoptotic Effects Alone and in Combination with Bio- and Chemotherapeutic Agents in Gastroenteropancreatic Neuroendocrine Tumor Cell Lines

By  

Neuroendocrinology, Vol. 91, Iss. 2, 2009-11 ,pp. : 121-130

Karger

Access to resources Recommend Favorite

VEGF Secretion by Neuroendocrine Tumor Cells Is Inhibited by Octreotide and by Inhibitors of the PI3K/AKT/mTOR Pathway

By  

Neuroendocrinology, Vol. 91, Iss. 3, 2010-04 ,pp. : 268-278

Karger

Access to resources Recommend Favorite